T. Hansen

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

I. Svane, P. thor Straten, M. Andersen, 2008, Cancer Immunology, Immunotherapy.

Neoantigen DNA vaccines are safe, feasible, and capable of inducing neoantigen-specific immune responses in patients with triple negative breast cancer

T. Vickery, R. Schreiber, T. Fleming, 2021, medRxiv.

Influence of Metronomic Cyclophosphamide and Interleukine-2 alone or Combined on Blood Regulatory T Cells in Patients with Advanced Malignant Melanoma Treated with Dendritic Cell Vaccines

I. Svane, P. Straten, M. Andersen, 2012 .